FindTrial
Sign In

Which drug is more effective in Gout Navkarshik Ghan Vati or Kaishor Guggulu.

A comparative study of Herbal Formulation Navkarshik Ghan Vati and Kaishor Guggulu in the management of Vatarakta w.s.r. to Gout

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/039962
Enrollment
100
Registered
2022-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E798- Other disorders of purine and pyrimidine metabolism

Interventions

None listed

Sponsors

SHRI KRISHNA AYUSH UNIVERSITY KURUKSHETRA HARYANA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients willing to participate in the trial 2 Patients between the age group of 20 years -70 years of either sex or religion 3 Patients having serum uric acid more then 7mg/dl in males and more then 6mg/dl in females with symptoms of Vatrakta

Exclusion criteria

Exclusion criteria: 1 Patients unwilling to participate in the trial 2 Patients below the age of 20 years and above 70 years of age 3 Patients with asymptomatic hyperuricemia and suffering from Secondary gout 4 Patients suffering from chronic respiratory cardiac hepatic renal and hormonal disorders 5 Pregnancy and lactating mothers

Design outcomes

Primary

MeasureTime frame
There is a significant result of Navkarshik Ghan Vati over Kaishor Guggulu in the management of Gout (Vatarakta)Timepoint: 8 WEEKS—

Secondary

MeasureTime frame
There is a significant result of Kaishor Guggulu over Navkarshik Ghan Vati in the management of Gout (Vatarakta)Timepoint: 8 weeks—

Countries

India

Contacts

Public ContactProf Balbir Singh

Sri Krishna Ayush University Kurukshetra Haryana

balbirsandhu63@gmail.com9813063424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026